Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease
JACC: Heart Failure · 2024-02 · 12 (2) · 409-411
DOI: 10.1016/j.jchf.2023.08.030 ↗Kurz gefasst
Leserbrief in der Zeitschrift JACC: Heart Failure, 2024-02. Verfasst von Masaki Ishiyama und 9 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hypertension, Pulmonary, Heart Failure, Heart Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 3 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Ishiyama, M., Fujimoto, N., Fukuoka, S., Omori, T., Moriwaki, K., Ogihara, Y., Nakamori, S., Kurita, T., Okamoto, R., & Dohi, K. (2024). Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease. JACC: Heart Failure, 12(2), 409-411. https://doi.org/10.1016/j.jchf.2023.08.030
Vancouver
Ishiyama M, Fujimoto N, Fukuoka S, Omori T, Moriwaki K, Ogihara Y, et al. Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease. JACC: Heart Failure. 2024;12(2):409-411. doi:10.1016/j.jchf.2023.08.030
BibTeX
@article{Ishiyama2024,
author = {Ishiyama, Masaki and Fujimoto, Naoki and Fukuoka, Shusuke and Omori, Taku and Moriwaki, Keishi and Ogihara, Yoshito and Nakamori, Shiro and Kurita, Tairo and Okamoto, Ryuji and Dohi, Kaoru},
title = {Effects of a Rho-Kinase Inhibitor in Patients With Pulmonary Hypertension Due to Left Heart Disease},
journal = {JACC: Heart Failure},
year = {2024},
volume = {12},
number = {2},
pages = {409--411},
doi = {10.1016/j.jchf.2023.08.030}
}
EUVIMED